CC-96673 (BMS-986358), an affinity-tuned anti-CD47 and CD20 bispecific antibody with fully functional fc, selectively targets and depletes non-Hodgkin's lymphoma
ABSTRACTCluster of differentiation 47 (CD47) is a transmembrane protein highly expressed in tumor cells that interacts with signal regulatory protein alpha (SIRPα) and triggers a "don't eat me" signal to the macrophage, inhibiting phagocytosis and enabling tumor escape from immunosurv...
Saved in:
Main Authors: | Dan Zhu (Author), Haralambos Hadjivassiliou (Author), Catherine Jennings (Author), David Mikolon (Author), Massimo Ammirante (Author), Sharmistha Acharya (Author), Jon Lloyd (Author), Mahan Abbasian (Author), Rama Krishna Narla (Author), Joseph R. Piccotti (Author), Katie Stamp (Author), Ho Cho (Author), Kandasamy Hariharan (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bispecific T cell engagers targeting CD20/CD3 in B-cell lymphoma: latest updates from 2023 EHA annual meeting
by: Shenhe Jin, et al.
Published: (2023) -
First‐in‐human study of JNJ‐67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome
by: Rupa Narayan, et al.
Published: (2024) -
Expression of RSK4, CD44 and MMP-9 is upregulated and positively correlated in metastatic ccRCC
by: Jing Ma, et al.
Published: (2020) -
Treatment of SHIV-infected, ART-suppressed rhesus macaques with bispecific HIVxCD3 DART® molecules
by: Daniel M. Gorman, et al.
Published: (2019) -
Suppression of c-Met-Overexpressing Tumors by a Novel c-Met/CD3 Bispecific Antibody
by: Huang L, et al.
Published: (2020)